Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Subgroup analyses revealed important differences based on comparator drugs: GLP-1RAs demonstrated greater effectiveness than SGLT2 inhibitors in preventing MALOs (IRR: 0.93, 95%CI: 0.87-0.99, P = 0.043), than DPP-4 inhibitors in preventing hepatic decompensation events (IRR: 0.74, 95%CI: 0.66-0.83, P = 0.003), and than insulin therapy in averting HCC development (IRR: 0.32, 95%CI: 0.13-0.80, P = 0.033) [64]
B.JagathaB.PadiadpuJ.RamanujanK
Endocrine Rev
Nrf2 activation by sulforaphane restores the age-related decrease of TH1 immunity: Role of dendritic cells
Side effects are rare but can include mild discomfort or allergic reactions
US$ 26.80
US$ 29.72
US$ 20.28
US$ 24.81
US$ 22.62
